Immunoblot analysis also showed that mTORC1 signaling was dramatically upregulated in the lesional skin of rosacea patients, which was not directly correlated with an increase in mTOR protein levels (Appendix Fig S1C). The gene discussed is MTOR; the disease is rosacea.